Detalhe da pesquisa
1.
Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolism.
EMBO Rep;
24(12): e57339, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37929643
2.
Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study.
Cancer Sci;
115(4): 1296-1305, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38402853
3.
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
Br J Cancer;
130(10): 1679-1686, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38575731
4.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
N Engl J Med;
383(10): 931-943, 2020 09 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32469185
5.
Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours.
Histopathology;
82(2): 242-253, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36130728
6.
Cost-Effectiveness of Tepotinib Versus Capmatinib for the Treatment of Adult Patients With Metastatic Non-Small Cell Lung Cancer Harboring Mesenchymal-Epithelial Transition Exon 14 Skipping.
Value Health;
26(4): 487-497, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36503033
7.
Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping.
Value Health;
26(8): 1155-1163, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36805576
8.
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib.
Future Oncol;
19(3): 217-228, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36749292
9.
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called MET exon 14 skipping.
Future Oncol;
19(10): 683-696, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36999526
10.
Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers.
Br J Cancer;
126(6): 889-898, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34963703
11.
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.
Jpn J Clin Oncol;
51(8): 1261-1268, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34037224
12.
Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.
Proc Natl Acad Sci U S A;
115(45): 11597-11602, 2018 11 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30348770
13.
YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
Proc Natl Acad Sci U S A;
115(26): E6030-E6038, 2018 06 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29875142
14.
TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
Proc Natl Acad Sci U S A;
113(38): E5655-64, 2016 09 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27601642
15.
Modelling the Effectiveness of Tepotinib in Comparison to Standard-of-Care Treatments in Patients with Advanced Non-small Cell Lung Cancer (NSCLC) Harbouring METex14 Skipping in the UK.
Target Oncol;
19(2): 191-201, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38492157
16.
Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis.
Radiother Oncol;
196: 110320, 2024 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38740091
17.
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation.
J Thorac Oncol;
19(3): 409-424, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37838086
18.
Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.
J Thorac Oncol;
19(5): 829-838, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38154515
19.
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.
Cancer;
119(2): 356-62, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22810899
20.
Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy.
Lancet Oncol;
13(10): e418-26, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23026827